No Data Yet
GE HealthCare has partnered with Indonesia's Ministry of Health to supply over 300 advanced CT scanners, part of the country's largest-ever healthcare infrastructure investment.
Boston Scientific shares fell 11% over the past month as a multi-year decline in earnings per share overshadowed strong revenue growth. This reflects a broader market shift where investors are scrutinizing profitability amid a tech and AI stock selloff.
AtriCure has successfully performed the first-in-human procedures using its novel dual-energy cardiac ablation platform, which combines Pulsed Field Ablation (PFA) and Radiofrequency Ablation (RFA). The technology demonstrated a sub-60-second ablation time, signaling a significant step in competing within the rapidly growing PFA market.
Boston Scientific has received expanded FDA approval for its FARAPULSE Pulsed Field Ablation (PFA) system, allowing its use for persistent atrial fibrillation. This regulatory milestone strengthens the company's leadership in the rapidly growing cardiac ablation market.
Mixed Q3 earnings in the medical devices sector triggered sharp, divergent stock reactions. Neogen Corporation (NEOG) soared on a revenue beat, while Baxter International (BAX) tumbled after missing analyst expectations, highlighting a highly selective investor market.